-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MJWOT2MvNFOrcZ/gf9AwAdowjNopctSMlR3NEYYlX+1CUjYirXpEstqgPfoF3nD6 GeM28RZf1D7RQ5mBuibmvg== 0001332432-06-000019.txt : 20060706 0001332432-06-000019.hdr.sgml : 20060706 20060706124844 ACCESSION NUMBER: 0001332432-06-000019 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060705 FILED AS OF DATE: 20060706 DATE AS OF CHANGE: 20060706 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Solexa, Inc. CENTRAL INDEX KEY: 0000913275 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 943161073 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 25861 INDUSTRIAL BLVD CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: 5106709300 MAIL ADDRESS: STREET 1: 25861 INDUSTRIAL BLVD CITY: HAYWARD STATE: CA ZIP: 94545 FORMER COMPANY: FORMER CONFORMED NAME: LYNX THERAPEUTICS INC DATE OF NAME CHANGE: 19931008 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Omead Ostadan CENTRAL INDEX KEY: 0001368212 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22570 FILM NUMBER: 06947109 BUSINESS ADDRESS: BUSINESS PHONE: 510-670-9300 MAIL ADDRESS: STREET 1: SOLEXA, INC. STREET 2: 25861 INDUSTRIAL BLVD. CITY: HAYWARD STATE: CA ZIP: 94545 3 1 edgar.xml PRIMARY DOCUMENT X0202 3 2006-07-05 0 0000913275 Solexa, Inc. SLXA 0001368212 Omead Ostadan C/O SOLEXA, INC. 25861 INDUSTRIAL BLVD. HAYWARD CA 94545 0 1 0 0 Vice President, Marketing Employee Stock Option (right to buy) 6.11 2005-05-31 2015-06-03 Common Stock 50000 D Employee Stock Option (right to buy) 8.60 2006-02-02 2016-02-02 Common Stock 75000 D Shares vest over four years from the date awarded with 25% vesting on the first anniversary of the date of grant, and the remainder vesting at a rate of 1/36 per complete month thereafter. Shares are exercisable once vested. Shares vest over five years from the date awarded with 20% vesting on the first anniversary of the date of grant, and the remainder vesting at a rate of 1/48 per complete month thereafter. Shares are exercisable once vested. Omead Ostadan 2006-07-06 -----END PRIVACY-ENHANCED MESSAGE-----